Ryuichiro Atarashi
Miyazaki, 8891692, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Administration of L-Type Bovine Spongiform Encephalopathy to Macaques to Evaluate Zoonotic Potential.
Journal: Emerging infectious diseases
Published: April 30, 2025
Oligoadenylate synthetase 1a suppresses prion infection through binding to cellular prion protein.
Journal: Brain : a journal of neurology
Published: December 23, 2024
Lysine residues are not required for proteasome-mediated proteolysis of cellular prion protein.
Journal: Biochemical and biophysical research communications
Published: September 26, 2024
Spontaneous generation of distinct prion variants with recombinant prion protein from a baculovirus-insect cell expression system.
Journal: Biochemical and biophysical research communications
Published: April 14, 2022
Central residues in prion protein PrPC are crucial for its conversion into the pathogenic isoform.
Journal: The Journal of biological chemistry
Published: March 09, 2022
Pentosan polysulfate induces low-level persistent prion infection keeping measurable seeding activity without PrP-res detection in Fukuoka-1 infected cell cultures.
Journal: Scientific reports
Published: February 18, 2022
Ethanolamine Is a New Anti-Prion Compound.
Journal: International journal of molecular sciences
Published: September 28, 2021
RT-QuIC as ultrasensitive method for prion detection.
Journal: Cell and tissue research
Published: September 17, 2021
Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
Journal: International journal of molecular sciences
Published: August 27, 2020
Dextran sulphate inhibits an association of prions with plasma membrane at the early phase of infection.
Journal: Neuroscience research
Published: July 24, 2020
Feasibility studies of radioiodinated pyridyl benzofuran derivatives as potential SPECT imaging agents for prion deposits in the brain.
Journal: Nuclear medicine and biology
Published: July 10, 2020
Administration of FK506 from Late Stage of Disease Prolongs Survival of Human Prion-Inoculated Mice.
Administration of FK506 from Late Stage of Disease Prolongs Survival of Human Prion-Inoculated Mice.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: June 03, 2020
Last Updated: 09/26/2026